Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04474301 · ClinicalTrials.gov registry record
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
A clinical trial of Melanoma and COVID-19 Infection, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 1,152
- Enrollment target
- 1
- Study location
NCT04474301 is a study of Melanoma and COVID-19 Infection that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 1,152 participants, above the 702-participant average among 266 other Melanoma trials with a reported enrollment target (64% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04474301, a study of Melanoma and COVID-19 Infection, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 1,152 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of this study is to gain an understanding of how experiences during the COVID-19 pandemic, regardless of COVID-19 status, may have impacted multiple domains of health-related quality of life and other areas such as COVID-19 specific psychological distress, and disruptions to health care, finances and social interactions. We will also evaluate the extent to which resiliency factors such as social support, perceived benefits under times of stress, and ability to manage stress may buffer associations between COVID-19 experiences and HRQoL. To meet these objectives, we have developed a 10-minute questionnaire that taps into these areas and is based on prior work addressing concerns of other pandemics or national crises. Participants will have previously consented to protocol PA15-0336 and have provided prior lifestyle data. This will allow us to connect the COVID-19 survey data with prior existing data.
Conditions Studied
Interventions
- OTHER Survey Administration
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,152 participants |
| Start Date | 2020-06-11 |
| Est. Completion | 2026-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04474301
The ClinicalTrials.gov registry entry for NCT04474301 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,152 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 702-participant average among 266 other Melanoma trials with a reported enrollment target (64% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Melanoma appearing as the primary indexed condition, and to 1 intervention - of which Survey Administration is the first listed.
NCT04474301 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04474301 about?
NCT04474301 is a clinical study titled "Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic". The primary purpose of this study is to gain an understanding of how experiences during the COVID-19 pandemic, regardless of COVID-19 status, may have impacted multiple domains of health-related quality of life and other areas such as COVID-19 specific psychological distress, and disruptions to heal...
What is the current status of trial NCT04474301?
This trial is currently recruiting. The enrollment target is 1,152 participants. The study started on 2020-06-11. Estimated completion is 2026-12-30.
What conditions does trial NCT04474301 study?
This clinical trial studies the following conditions: Melanoma, COVID-19 Infection.
What interventions are being tested in trial NCT04474301?
The interventions under investigation include: Survey Administration (OTHER).
Who is sponsoring clinical trial NCT04474301?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04474301 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Melanoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
RECRUITING · NA
-
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
RECRUITING · Phase 2
-
Dabrafenib and/or Trametinib Rollover Study
RECRUITING · Phase 4
-
Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED
RECRUITING · Phase 2
-
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
RECRUITING · Phase 1
-
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.